ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 11 filers reported holding ZEALAND PHARMA A S in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $359,000 | -5.5% | 10,000 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $380,000 | +8.6% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $350,000 | +1.4% | 10,000 | 0.0% | 0.00% | -20.0% |
Q1 2020 | $345,000 | +3.9% | 10,000 | 0.0% | 0.01% | +66.7% |
Q4 2019 | $332,000 | +30.7% | 10,000 | 0.0% | 0.00% | +50.0% |
Q3 2019 | $254,000 | +17.6% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $216,000 | +27.1% | 10,000 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $170,000 | +46.6% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $116,000 | -29.7% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $165,000 | +29.9% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $127,000 | -15.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $150,000 | +10.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $136,000 | -88.2% | 10,000 | -83.3% | 0.00% | -87.5% |
Q3 2017 | $1,152,000 | – | 60,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FARALLON CAPITAL MANAGEMENT LLC | 1,010,000 | $25,614,000 | 0.19% |
AWM Investment Company, Inc. | 19,981 | $507,000 | 0.11% |
WELLINGTON MANAGEMENT GROUP LLP | 1,686,496 | $42,768,000 | 0.01% |
STATE OF WISCONSIN INVESTMENT BOARD | 44,092 | $1,118,000 | 0.00% |
ROYCE & ASSOCIATES LP | 10,000 | $254,000 | 0.00% |
Winslow, Evans & Crocker, Inc. | 236 | $6,000 | 0.00% |
JANE STREET GROUP, LLC | 11,942 | $304,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 8,537 | $216,000 | 0.00% |
Tower Research Capital LLC (TRC) | 39 | $1,000 | 0.00% |